Dr. Naveen Pemmaraju

0:22:41

Naveen Pemmaraju, MD Drugs Novel Agents for MPNs in 2024

0:04:19

MPN Hero Dr. Naveen Pemmaraju: Moving the Field Forward

0:01:49

Meet leukemia oncologist Naveen Pemmaraju, M.D.

0:02:37

Myelofibrosis Symptoms and Side Effects | Why Speaking Up Is Vital

0:05:35

Common MPN Symptoms | What Are They and How Are They Managed?

0:02:27

How Is MPN Treatment Effectiveness Monitored?

0:03:30

Top Three Questions for MPN Researchers With Dr. Pemmaraju

0:01:46

Dr Naveen Pemmaraju Outlines the Symptoms of Myelofibrosis

0:02:42

Why You Should Speak Up About MPN Symptoms and Treatment Side Effects

0:02:05

When Should Myelofibrosis Mutational Testing Be Repeated?

0:21:14

How to treat Myelofibrosis - Discussion with Dr. Naveen Pemmaraju

0:02:20

Emerging Treatments in Myelofibrosis Care

0:01:54

Dr. Pemmaraju on Clinical Trial Results of LCL161 in High-Risk Myelofibrosis

0:30:15

Evolving Targets for MPN Therapy - Dr. Naveen Pemmaraju

0:07:08

Dr Naveen Pemmaraju highlights JIPO's special issue on rare hematologic malignancies

0:02:32

Myelofibrosis Care | Impact of Diet & Lifestyle Modifications

0:02:26

Increased MPN Symptoms | What Does It Mean for Patients?

0:02:39

Efficacy of Navitoclax and Ruxolitinib | Naveen Pemmaraju, MD | EHA 2024

0:04:20

Emotional Health | Why It’s Vital for Myelofibrosis Patients to Share Concerns

0:03:53

How to Engage in Your MPN Treatment Decisions

0:05:00

Expert Advice | Living and Thriving With an MPN

0:01:51

Dr. Pemmaraju on Methods to Treat Anemia in MPNs

0:03:28

Naveen Pemmaraju: 'how I Tweet'

0:02:09

What Can MPN Patients Expect When Starting a New Treatment?